Come up with a name for your new list and we'll add to it:
Ambiopharm raised a round of funding on November 20, 2014. Investors include
MVM Life Science Partners.
AmbioPharm (APi) has developed a new business model responsive to an accelerating trend to drive down costs of manufacturing peptides. The company has established a new custom peptide supply service d…